Form 8-K - Current report:
SEC Accession No. 0001558370-24-009561
Filing Date
2024-06-27
Accepted
2024-06-27 17:21:01
Documents
17
Period of Report
2024-06-21
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K krbp-20240621x8k.htm   iXBRL 8-K 52023
2 EX-3.1 krbp-20240621xex3d1.htm EX-3.1 18918
3 EX-10.1 krbp-20240621xex10d1.htm EX-10.1 66444
4 EX-10.2 krbp-20240621xex10d2.htm EX-10.2 172057
5 GRAPHIC krbp-20240621xex3d1001.jpg GRAPHIC 2692
  Complete submission text file 0001558370-24-009561.txt   497141

Data Files

Seq Description Document Type Size
6 EX-101.SCH krbp-20240621.xsd EX-101.SCH 3405
7 EX-101.LAB krbp-20240621_lab.xml EX-101.LAB 17231
8 EX-101.PRE krbp-20240621_pre.xml EX-101.PRE 10926
21 EXTRACTED XBRL INSTANCE DOCUMENT krbp-20240621x8k_htm.xml XML 5213
Mailing Address 7707 FANNIN ST. SUITE 140 HOUSTON TX 77054
Business Address 7707 FANNIN ST. SUITE 140 HOUSTON TX 77054 832-968-4888
Kiromic Biopharma, Inc. (Filer) CIK: 0001792581 (see all company filings)

EIN.: 464762913 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39619 | Film No.: 241080481
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)